• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    More On NBS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Neostem, Inc. (NBS)

    -NasdaqCM
    2.25 0.00(0.00%) Jun 5, 3:59PM EDT
    Prev Close:2.25
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:13.50
    Beta:1.37
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:2.03 - 7.23
    Volume:0
    Avg Vol (3m):760,553
    Market Cap:116.83M
    P/E (ttm):N/A
    EPS (ttm):-1.72
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback